Someone else already paid for the growth: management describes an outside party bearing the cost, risk, or work that exp
The model's full reasoning — Q4 2022 call → NOWe need to determine if management describes an outside party bearing cost/risk/work of expanding the company's business. The transcript discusses various partnerships, but we need to see if any are described as real, underway, with cost on other side, and payoff ahead. Key points: Sanofi collaboration for Dupixent, but that's a profit-sharing arrangement, not outside party bearing expansion cost. Libtayo transaction with Sanofi - Regeneron acquired full rights, so that's insourcing. Alnylam collaboration for siRNA - they are developing together, but is Alnylam bearing cost? The transcript says "our collaboration with Alnylam" and they are initiating studies, but it's a collaboration, not clearly outside party bearing cost. Also, the question asks about expanding company's business - the company's own pipeline is being developed by Regeneron itself. There is no mention of franchisees, dealers, etc. The only possible is the collaboration with Alnylam and Intellia, but those are joint development, not clearly outside party bearing cost. Also, the company is investing heavily in R&D itself. The transcript does not convey that outside parties are financing or executing the growth. The company is spending its own money on R&D, manufacturing, etc. So answer NO. Check: "we are planning a broad and multi-pronged approach" - that's future. "we are initiating a Phase 2 study" - that's Regeneron's own. No outside party bearing cost. So NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| VVV | Valvoline Inc. | Q1 2022 | 2022-02-09 | C+ |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PCRX | Pacira BioSciences, Inc. | Q4 2017 | 2018-02-28 | C |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| SNA | Snap-on Incorporated | Q3 2017 | 2017-10-19 | B |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| MGNX | MacroGenics, Inc. | Q3 2016 | 2016-11-02 | D |
| CRIS | Curis, Inc. | Q1 2016 | 2016-05-09 | C |
INST · Q4 2017 → YESThe question is about whether management describes an outside party already bearing the cost, risk, or work of expanding the company's business, with the effort real and underway now, but the resultin...YES The transcript shows management describing the Paychex partnership as a white-label reseller arrangement where Paychex is already bearing the cost, risk, and work of expanding Instructure’s business by offering Bridge Learn to its 0.5 million customers (6 million users) using its own salesforce and customer base — a real, underway effort since the partnership was entered into and integration is already in progress. Management explicitly states Paychex owns the customers and will sell the product, while Instructure is only powering the backend, and the resulting revenue is still mostly ahead (they are optimistic about significant success by year-end). This matches 100% of the required criteria.
PLAB · Q2 2017 → YESThe question is about whether management describes an outside party already bearing the cost, risk, or work of expanding the company's business, with the effort real and underway now, but the resultin...YES The transcript shows management describing the DNP JV as an outside party already bearing the bulk of the expansion costs and risks for the new China facility (the $160 million Xiamen site, previously announced as a company-led greenfield build last August). Peter Kirlin notes they will "utilize all cash held in Taiwan and greater reduced to risk of ramping of our new factory in China," while Sean Smith confirms they are "sharing that total investment of 160 million as we in essence have a 50-50 partnership, however we will consolidate it" and will "share equitably the startup cost.
YUM · Q2 2018 → YESThe question is about whether management describes an outside party already bearing the cost, risk, or work of expanding the company's business, with the effort real and underway now, but the resultin...YES The transcript shows management describing real, ongoing outside efforts by franchisees and partners already bearing the cost, risk, and work of expansion. Franchisees are actively spending their own capital to open units (e.g., 482 net new units YTD vs. 317 last year; KFC opening nearly 200 2Q units; Pizza Hut 6% net new unit growth; Taco Bell 9 international units), with the company 97% franchised and on track for 98%. These efforts are already in motion and contributing to current results, while management highlights acceleration and future ramp (e.g.